Target intelligence / Profile preview

Lysine rich nucleolar protein 1 pseudogene 3 (KNOP1P3)

Target
KNOP1P3
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA), Other
01

Overview

Lysine rich nucleolar protein 1 pseudogene 3 (KNOP1P3) is a human pseudogene, meaning it is a DNA segment that closely resembles a functional gene but is generally considered non-functional in terms of coding for a final protein product[3][2]. Like other pseudogenes, KNOP1P3 may be transcribed into RNA but lacks the capability to produce a functional protein due to disabling mutations such as premature stop codons or insertions/deletions that disrupt the coding sequence[2]. Some pseudogene transcripts, in general, have gained attention for potential regulatory functions, including acting as competing endogenous RNAs (ceRNAs) by binding microRNAs and thereby affecting the expression of their protein-coding gene counterparts[1][4]. However, there is no direct evidence KNOP1P3 itself has such a function; its precise biological role, if any, remains uncharacterized.\n\nKNOP1P3 is not considered a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), nor is it associated with any known drug interactions, mechanisms of drug action, or biomarker roles. There are no disease associations or safety concerns documented for this pseudogene[3]. It is, by classification, a member of the “Other” or “non-coding RNA” molecular classifications, specifically as a pseudogene[3][2].

Other names
Lysine-rich nucleolar protein 1 pseudogene 3KNOP1P3
02

Biological functions

Regulatory RNA (potential)Competes for miRNA binding (potential)Other
03

Disease associations

Other

Beyond the preview

Go deeper on Lysine rich nucleolar protein 1 pseudogene 3 (KNOP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine rich nucleolar protein 1 pseudogene 3 (KNOP1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call